Long-term toxicity of immune suppression in juvenile rheumatic diseases

Rheumatology

Volumn 38, Issue 8, 1999, Pages 743-746

  Laxer, R M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

AVASCULAR NECROSIS; AZOOSPERMIA; BONE DISEASE; CANCER; CATARACT; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORTICOSTEROID THERAPY; EMBRYOPATHY; GLAUCOMA; GONAD DYSFUNCTION; GROWTH DISORDER; HUMAN; HYPERTENSION; HYPERTRICHOSIS; HYPOGAMMAGLOBULINEMIA; IMMUNOMODULATION; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LIVER FIBROSIS; MENSTRUATION DISORDER; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RETINOPATHY; RHEUMATIC DISEASE; SCLERODERMA; SIDE EFFECT; SKIN ATROPHY; SYSTEMIC VASCULITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ALKYLATING AGENTS; ANTIRHEUMATIC AGENTS; CHILD; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; RHEUMATIC DISEASES; TIME;

EID: 0032704072     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.8.743     Document Type: Conference Paper

References (25)

1. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994;93:967-76.
2. Katzman DK, Zipursky RB. Adolescents with anorexia nervosa: the impact of the disorder on bones and brains. Ann NY Acad Sci 1997;28:817:127-37.
3. Ilowite NT. Hyperlipidemia and the rheumatic diseases. Curr Opin Rheumatol 1996;8:455-8.
4. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:2226-34.
5. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37:316-28.
6. Stanisavljevic S, Babcock AL. Fractures in children treated with methotrexate for leukemia. Clin Orthop 1977; 125:139-44.
7. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582-5.
8. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997;40:971-3.
9. Bleyer WA. Methotrexate induced lymphoma? J Rheumatol 1998;25:404-7.
10. Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol 1997;24:2035-7.
11. Arellano F, Krupp P. Malignancies in rheumatoid arthritis: Conclusions of an international review. Br J Rheumatol 1994;33(suppl. 1):72-5.
12. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee. J Rheumatol 1991;18:809-14.
13. Savolainen HA, Kautiainen H, Isomaki H, Aho K, Verronen P. Azathioprine in patients with juvenile chronic arthritis: a longterm followup study. J Rheumatol 1997;24:2444-50.
14. Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R, Ciruelo E, Gomez-Reino FJ, Muley R et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 1995;34:737-41.
15. Wang CL, Wang F, Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 1995;4:11-4.
16. Boumpas DT, Austin HA III, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. X. Ann Intern Med 1993;119:366-9.
17. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
18. Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993;122:26-31.
19. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. J Am Med Assoc 1988;259:2123-5.
20. Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 1978;92:299-303.
21. Palmer RG, Ansell BM. Acute leukaemia related to chlorambucil therapy for juvenile chronic arthritis. Clin Exp Rheumatol 1984;2:81-3.
22. Buriot D, Prieur AM, Lebranchu Y, Messerschmitt J, Griscelli C. Acute leukemia in 3 children with chronic juvenile arthritis treated with chlorambucil. Arch Fr Pediatr 1979;36:592-8.
23. Westhovens R, Verwilghen J, Dequeker J. Total lymphoid irradiation in rheumatoid arthritis. A ten-year followup. Arthritis Rheum 1997;40:426-9.
24. Foster BJ, Duffy CM, Sharma AK. Systemic juvenile rheumatoid arthritis complicated by two different renal lesions. Pediatr Nephrol 1998;12:113-6.
25. Hashkes PJ, Lovell DJ. Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy. Clin Exp Rheumatol 1996;14:673-5.